Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus

Open access
Pratley, Richard E., Rosenstock, Julio, Heller, Simon R., Sinclair, Alan, Heine, Robert J., Kiljański, Jacek, Brusko, Cynthia S., Duan, Ran, Festa, Andreas · 2018 · Journal of Diabetes Science and Technology

Abstract

Background: Few studies have evaluated continuous glucose monitoring (CGM) in older patients with type 2 diabetes mellitus (T2DM) not using injectable therapy. CGM is useful for investigating hypoglycemia and glycemic variability, which is associated with complications in T2DM. Methods: A CGM substudy of Individualized treatMent aPproach for oldER patIents in a randomized trial in type 2 diabetes Mellitus (IMPERIUM)) was conducted. Patients were vulnerable (moderately ill and/or frail) older (≥65 years) individuals with suboptimally controlled T2DM. Strategy A comprised glucose-dependent therapies (n = 26) with a nonsulfonylurea oral antihyperglycemic medication (OAM) and a glucagon-like peptide-1 receptor agonist as the first injectable. Strategy B comprised non-glucose-dependent therapies (n = 21) with sulfonylurea as the preferred OAM and insulin glargine as the first injectable. Primary endpoints were duration and percentage of time spent with blood glucose (BG) ≤70 mg/dL over 24 hours at week 24. Results: Duration and percentage of time spent with hypoglycemia at ≤70 mg/dL were similar for Strategy A and Strategy B; glycemic control improved similarly in both arms (LSM change in HbA1c at week 24; A = −1.2%, B = −1.4%). Duration and percentage time spent with euglycemia and hyperglycemia were also similar in both arms. However, Strategy A was associated with lower within-day (21.1 ± 1.2 vs 25.1 ± 1.4, P = .046) and between-day (5.4 ± 1.0 vs 9.1 ± 1.3, P = .038) BG variability (coefficient of variance [LSM ± SE]) at week 24. Conclusions: This CGM substudy in older patients with T2DM showed lower within- and between-day BG variability with glucose-dependent therapies but similar HbA1c reductions and hypoglycemia duration with glucose-independent strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1932296818776993

Cites

Statistics

Figures

Figure 1A. Duration of hypoglycemia during a 24-hour period at baseline and week 24. Data are presented as least squares mean.
Figure 1A. Duration of hypoglycemia during a 24-hour period at baseline and week 24. Data are presented as least squares mean.CC BY-NC · PubMed Central
Figure 1B. Percentage of time spent in euglycemia and hyperglycemia during a 24-hour period at baseline and week 24. Data are presented as least squares mean.
Figure 1B. Percentage of time spent in euglycemia and hyperglycemia during a 24-hour period at baseline and week 24. Data are presented as least squares mean.CC BY-NC · PubMed Central
Figure 2. Change in HbA1c from baseline to week 24. Data are presented as least squares mean ± standard error.
Figure 2. Change in HbA1c from baseline to week 24. Data are presented as least squares mean ± standard error.CC BY-NC · PubMed Central
Figure 3A. Duration of hypoglycemia during nocturnal period (midnight to 0600 hours). Data are presented as least squares mean.
Figure 3A. Duration of hypoglycemia during nocturnal period (midnight to 0600 hours). Data are presented as least squares mean.CC BY-NC · PubMed Central
Figure 3B. Percentage of time spent with hypoglycemia during nocturnal period (midnight to 0600 hours). Data are presented as least squares mean.
Figure 3B. Percentage of time spent with hypoglycemia during nocturnal period (midnight to 0600 hours). Data are presented as least squares mean.CC BY-NC · PubMed Central
Figure 4. Glycemic variability over 24-hour period.
Figure 4. Glycemic variability over 24-hour period.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 34 · Cited by 13

Research works printed but not linked: 1

  1. Du YF, 2014, Clin Interv Aging, 9, 1963

Metadata

Authors
Pratley, R. E., Rosenstock, J., Heller, S. R., Sinclair, A., Heine, R. J., Kiljański, J., Brusko, C. S., Duan, R., & Festa, A.
Affiliations
  • AdventHealth (US)
  • Medical City Dallas Hospital (US)
  • University of Sheffield (GB)
  • Foundation for Diabetes Research in Older People, Diabetes Frail Limited, Worcestershire, UK
  • Eli Lilly (United States) (US)
  • Eli Lilly & Company, Warsaw, Poland
  • University of Vienna (AT)
Corresponding author
Pratley, Richard E.
Venue
Journal of Diabetes Science and Technology
Published
2018-06-12
Volume
12
Issue
6
Pages
1184-1191
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2808638094
Cited by
13
References
34
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 5 · 2022: 1 · 2021: 2 · 2020: 1
FWCI
0.60
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Diabetes Science and Technology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Eli Lilly and Company
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
Keywords
type 2 diabetes, older adults, glycemic variability, continuous glucose monitoring, sulfonylureas, insulin glargine, GLP-1 receptor agonists, hypoglycemia, HbA1c, vulnerable patients
MeSH terms
Insulin Glargine, Glucagon-Like Peptide-1 Receptor Agonists, Age Factors, Aged, Aged, 80 and over, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Male, Sulfonylurea Compounds, Blood Glucose Self-Monitoring, Incidence, Frail Elderly, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus. https://app.cochat.ai/papers/10.1177/1932296818776993
The paper
Pratley, R. E., Rosenstock, J., Heller, S. R., Sinclair, A., Heine, R. J., Kiljański, J., Brusko, C. S., Duan, R., & Festa, A. (2018). Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296818776993

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.